Learn more about Evernorth Therapy Link, a new solution designed to identify and support patients who can benefit most from gene or cell therapies.

Meet Kenya, an Accredo patient who is living with multiple sclerosis (MS). Watch the video to learn more about her journey of managing her condition with the support of Accredo Specialty Pharmacy.

GLP-1 medications drive unprecedented growth in traditional drug spending, surpassing specialty drug trends for the first time.

Cancer rates are rising, yet early detection remains underused — despite its power to improve outcomes and reduce emotional strain.

Optimizing benefit communications can lead to better outcomes, fewer downstream costs and higher employee satisfaction.

As a dedicated rare disease partner, CuraScript SD helps ensure timely access to life-changing treatments.